Menu Search
Equities

XWELL Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
XWEL*:MEX

XWELL Inc

Actions
  • Price (MXN)50.44
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta1.4193
Data delayed at least 20 minutes, as of Nov 03 2025.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.

  • Revenue in USD (TTM)29.52m
  • Net income in USD-17.40m
  • Incorporated2006
  • Employees246.00
  • Location
    XWELL Inc254 WEST 31ST STREET, 11TH FLOORNEW YORK 10001United StatesUSA
  • Phone+1 (212) 750-9595
  • Fax+1 (302) 636-5454
  • Websitehttps://www.xwell.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.